FindTrial
Sign In

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00249093
Enrollment
20
Registered
2005-11-07
Start date
2005-10-31
Completion date
2007-04-30
Last updated
2007-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Interventions

DRUGoxygen

Sponsors

The norwegian association for heart and lung patients
CollaboratorUNKNOWN
LHL Helse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* COPD patients (male/female)given long-term oxygen treatment * Able to perform two separate walking tests

Exclusion criteria

* Severe heart failure

Design outcomes

Primary

MeasureTime frame
dyspnea—
exercise tolerance—

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026